跳至主要内容
临床试验/NCT05058508
NCT05058508招募中不适用

LCI-PED-NOS-EXER-001: Just Move. A Randomized Controlled Trial Investigating Exercise in Pediatric Oncology Patients

Wake Forest University Health Sciences2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年3月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
2
主要终点
Potential benefit of increasing/maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment

研究概览

简要总结

The purpose of this study is to see if there are physical and emotional benefits to participating in a structured exercise regimen for those who are ages 2-25, are newly diagnosed with a blood or solid tumor cancer, and are currently undergoing or will begin cancer treatment.

详细描述

This is a randomized, controlled trial to investigate if a structured exercise regimen will have benefit relative to the control arm by increasing and /or maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment as measured by 6-Minute Walk test and BOT-2 Brief or PDMS-2.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
2 Years 至 25 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Ages 2-25 at time of consent
  • Subject has newly diagnosed cancer per Investigator, and is planning to undergo chemotherapy for treatment of malignancy for at least 3 full cycles
  • Ability of subject (and/or parent/guardian) to read and understand the English or Spanish language
  • As determined and documented by the enrolling investigator, ability of the subject to understand and comply with study procedures for the entire length of the study
  • Subject has newly diagnosed cancer per Investigator and is planning to undergo chemotherapy, immunotherapy, or other systemically delivered for treatment of malignancy. Subjects are allowed to be enrolled up to 21 days after initiating cancer treatment.
  • Receiving oncologic care at Levine Children's Cancer and Blood Disorders Clinic.
  • Subject is anticipated to receive at least 3 full cycles of chemotherapy or other systemic cancer treatment.
  • Not participating in another clinical trial that precludes participating in additional nondrug clinical trials.

排除标准

  • Known cardiac dysfunction that, in the opinion of the investigator, would be unsafe for the child to participate in the exercise program
  • Any other uncontrolled intercurrent illness/medical condition or psychiatric illness/social situations that would limit compliance with study requirements or would be considered unsafe for the child to participate as determined by the Investigator.
  • Recent (within 4 weeks of enrollment) or planned surgery that will result in prolonged limited mobility not amendable to exercise modifications per investigator discretion
  • Primary CNS Tumor
  • Osteosarcoma

研究组 & 干预措施

EXER

Experimental

"Just Move" exercises

干预措施: "Just Move" Exercise (Other)

SOC EXER

Experimental

Standard of Care Exercise

干预措施: Standard of Care Exercise (Other)

结局指标

主要结局

Potential benefit of increasing/maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment

时间窗: 18 month period

Investigate if 30 minutes of exercise, five days per week, will have benefit relative to the control arm by increasing and/or maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment as measured by 6-Minute Walk test

次要结局

  • Adverse Events Related to Exercise Program(up to 18 months)
  • Adverse Event Rate(up to 18 months)
  • Quality of Life measured by the PedsQL Cancer Module(up to 18 months)
  • Subject adherence to exercise regimen(up to 18 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验